文献速递外周动脉疾病

编辑推荐——下肢血管内血运重建与旁路手术治疗慢性肢体威胁性缺血的回顾性欧洲多中心倾向性评分匹配队列研究

Editor's Choice - Infra-inguinal Endovascular Revascularisation and Bypass Surgery for Chronic Limb Threatening Ischaemia: a Retrospective European Multicentre Cohort Study with Propensity Score Matching.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-06-27

这项回顾性欧洲多中心队列研究纳入793例慢性肢体威胁性缺血患者,经倾向性评分匹配后分析236对。结果显示,旁路手术组5年无截肢生存率显著优于血管内治疗组(60.5±3.6% vs 35.3±3.6%,p<.001),大截肢风险更低(HR 0.66,95%CI 0.47-0.92),6个月创面愈合概率更高,但住院时间更长(8天 vs 4天)。

要点

  • 旁路手术组5年无截肢生存率显著高于血管内治疗组(60.5±3.6% vs 35.3±3.6%,p<.001)。
  • 旁路手术组大截肢风险显著低于血管内治疗组(HR 0.66,95%CI 0.47-0.92,p=.014)。
  • 旁路手术组6个月创面愈合概率显著优于血管内治疗组,但住院时间更长(8天 vs 4天,p=.001)。

核心结论

  • 在慢性肢体威胁性缺血患者中,下肢旁路手术相比血管内治疗提供了显著更高的无截肢生存率和创面愈合概率。

研究设计与样本

  • 回顾性、多中心研究,评估首次接受腹股沟下旁路手术或血管内治疗的慢性肢体威胁性缺血患者。
  • 共793例患者符合纳入标准,经倾向性评分匹配后分析236对匹配病例,平均随访52个月。

主要发现

  • 旁路手术组5年无截肢生存率为60.5±3.6%,血管内治疗组为35.3±3.6%,差异显著(p<.001)。
  • 旁路手术组大截肢61例(25.8%),血管内治疗组85例(36.0%),HR 0.66(95%CI 0.47-0.92;p=.014)。
  • 旁路手术组6个月创面愈合概率显著优于血管内治疗组(p=.003)。
  • 血管内治疗组中位住院时间4天,旁路手术组8天,差异显著(p=.001)。
  • 紧急再干预和再入院率均较高,两组间无显著差异。

关键数值与推荐

  • 236例旁路手术中,自体旁路移植190例(80.5%),其中膝下旁路151例(64.0%)。
  • 236例血管内治疗中,靶病变位于股腘段81例(34.3%),股腘及膝下段101例(42.8%),膝下段54例(22.9%)。
  • 无截肢生存率比较:旁路手术组60.5±3.6% vs 血管内治疗组35.3±3.6%(5年,p<.001)。
  • 大截肢风险:HR 0.66(95%CI 0.47-0.92;p=.014),旁路手术组较血管内治疗组降低。
  • 创面愈合概率比较p=.003,旁路手术组优于血管内治疗组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to compare the long term efficacy of lower limb bypass with that of endovascular treatment (EVT) in patients with chronic limb threatening ischaemia (CLTI). METHODS: This retrospective, multicentre study evaluated the outcomes of patients with CLTI who underwent first time infra-inguinal bypass or EVT. The primary outcome was to compare amputation free survival (AFS) rates between the two propensity score matched groups. The secondary outcome was to compare wound healing within the first six months. Major adverse events were compared according to the type of revascularisation. RESULTS: Overall, 793 patients fulfilled the eligibility criteria, from whom 236 propensity score matched pairs were analysed. The mean follow up was 52 months. The 236 bypass procedures included 190 autogenous bypass grafts (80.5%), 151 (64.0%) of which were infrapopliteal. Among the 236 EVT procedures, the target lesion was the femoropopliteal segment in 81 patients (34.3%), the femoropopliteal and infrapopliteal segments in 101 patients (42.8%), and the infrapopliteal segment in 54 patients (22.9%). AFS was significantly better in the bypass group at five years (60.5 ± 3.6%) compared with the EVT group (35.3 ± 3.6%) (p < .001). Major amputation occurred in 61 patients (25.8%) in the bypass group and 85 patients (36.0%) in the EVT group (HR 0.66, 95% CI 0.47 - 0.92; p = .014). The probability of healing was significantly better in the bypass group at six months compared with the EVT group (p = .003). The median length of stay was shorter for the EVT group (4 days) than for the bypass group (8 days) (p = .001). Urgent re-intervention and re-admission rates were high and did not differ significantly between the groups. CONCLUSION: This study has shown that lower limb bypass surgery offered a significantly higher probability of AFS and wound healing compared with EVT in patients with CLTI.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ricco JB, Roiger RJ, Schneider F, et al. Editor's Choice - Infra-inguinal Endovascular Revascularisation and Bypass Surgery for Chronic Limb Threatening Ischaemia: a Retrospective European Multicentre Cohort Study with Propensity Score Matching. Eur J Vasc Endovasc Surg. 2023. PMID: 37385368. doi:10.1016/j.ejvs.2023.06.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。